NDC properties for "0.8 ML Hulio 50 MG/ML Auto-Injector" (RxCUI 2640410)
About this data
The tables show NDC propoerties for 0.8 ML Hulio 50 MG/ML Auto-Injector with the RxCUI 2640410
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Hulio 50 MG/ML Auto-Injector (RxCUI 2640410)
| BLA | BLA761154 |
|---|---|
| MMSL_CODE | BD39564 |
| RxCUI | 2640410 |
| SPL_SET_ID | 661ad70b-c313-2899-8a7e-7a67bd897ca9 |
| SPL_SET_ID | a0518a75-8240-4172-aff7-1e03fd9523be |
| Prescribable Synonym | Hulio 40 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML Hulio 50 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector [Hulio] |
| RxNorm Synonym | 0.8 ML Hulio 50 MG/ML Auto-Injector |
| RxNorm Synonym | Hulio 40 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2640410) |
NDC Properties
NDC Item 49502038002
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-02 |
| NDC Item | 49502038002 |
| Packaging | 2 TRAY in 1 KIT (49502-380-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-540-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-542-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-380 |
NDC Item 49502038006
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-06 |
| NDC Item | 49502038006 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-380 |
NDC Item 83257001932
| NDC 9 | 83257-019 |
|---|---|
| NDC 10 | 83257-019-32 |
| NDC Item | 83257001932 |
| Packaging | 2 TRAY in 1 KIT (83257-019-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-019 |
NDC Item 49502038002
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-02 |
| NDC Item | 49502038002 |
| Packaging | 2 TRAY in 1 KIT (49502-380-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-540-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-542-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-380 |
NDC Item 49502038006
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-06 |
| NDC Item | 49502038006 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-380 |
NDC Item 83257001932
| NDC 9 | 83257-019 |
|---|---|
| NDC 10 | 83257-019-32 |
| NDC Item | 83257001932 |
| Packaging | 2 TRAY in 1 KIT (83257-019-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-019 |
NDC Item 49502038002
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-02 |
| NDC Item | 49502038002 |
| Packaging | 2 TRAY in 1 KIT (49502-380-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-540-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-542-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-380 |
NDC Item 49502038006
| NDC 9 | 49502-380 |
|---|---|
| NDC 10 | 49502-380-06 |
| NDC Item | 49502038006 |
| BLA | BLA761154 |
| FDA SPL set id | 761441 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-380 |
NDC Item 83257001932
| NDC 9 | 83257-019 |
|---|---|
| NDC 10 | 83257-019-32 |
| NDC Item | 83257001932 |
| Packaging | 2 TRAY in 1 KIT (83257-019-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 789322 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-019 |